Update Breast Cancer 2020 Part 4 - Advanced Breast Cancer

Hans Tesch1, Volkmar Müller2, Achim Wöckel3

  • 1Oncology Practice at Bethanien Hospital Frankfurt, Frankfurt, Germany.

Insights

Targeted therapies are improving advanced breast cancer treatment by focusing on specific genetic mutations like PIK3CA and BRCA1/2. This review covers new approaches and integrating them into current treatment sequences for better patient outcomes.

Area of Science:

  • Oncology
  • Molecular Biology
  • Pharmacology

Background:

  • Targeted therapies show increasing effectiveness in advanced breast cancer treatment.
  • Recent advancements focus on specific molecular alterations for personalized treatment strategies.

Purpose of the Study:

  • To review the latest information on targeted therapies for advanced breast cancer.
  • To discuss the integration of new treatment methods based on molecular patterns.

Main Methods:

  • Literature review of recent studies on targeted therapies in breast cancer.
  • Analysis of treatment strategies for specific mutations (PIK3CA, BRCA1/2).

Main Results:

  • PARP inhibitors have improved outcomes for patients with BRCA1/2 mutations.
  • Targeted therapies for PIK3CA mutations are emerging for HR+/HER2 advanced breast cancer.

Conclusions:

  • Personalized medicine based on molecular profiling is expanding treatment options.
  • Integrating novel therapies into existing sequences is crucial for optimizing patient care.

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
542
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.5K
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
726
Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
7.3K